We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+8.44%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$3.15B
AUM Growth
+$171M
Cap. Flow
-$50.7M
Cap. Flow %
-1.61%
Top 10 Hldgs %
39.38%
Holding
234
New
3
Increased
16
Reduced
102
Closed
4

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$69.5M
2
APO icon
Apollo Global Management
APO
+$21.5M
3
BB icon
BlackBerry
BB
+$7.83M
4
LUMN icon
Lumen
LUMN
+$5.06M
5
OAK
OAKTREE CAPITAL GROUP, LLC
OAK
+$1.86M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$20.2M
2
JEF icon
Jefferies Financial Group
JEF
+$15.3M
3
BAX icon
Baxter International
BAX
+$13.3M
4
LBTYA icon
Liberty Global Class A
LBTYA
+$12.6M
5
ABT icon
Abbott
ABT
+$6.71M

Sector Composition

Rank Sector Weight
1 Financials 29.01%
2 Healthcare 16.47%
3 Technology 12.09%
4 Communication Services 10.94%
5 Energy 10.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESGR
1
DELISTED
Enstar Group
ESGR
$151M 4.8%
725,347
-15,874
-2% -$3.37M
MSFT icon
2
Microsoft
MSFT
$2.9T
$147M 4.66%
1,282,628
-44,585
-3% -$4.83M
LUMN icon
3
Lumen
LUMN
$6.43B
$137M 4.36%
6,469,678
+241,858
+4% +$5.06M
MTDR icon
4
Matador Resources
MTDR
$6.04B
$135M 4.28%
4,082,146
-22,199
-0.5% -$709K
APO icon
5
Apollo Global Management
APO
$69B
$131M 4.16%
3,794,769
+617,566
+19% +$21.5M
BX icon
6
Blackstone
BX
$104B
$131M 4.15%
3,433,180
+402
+0% +$14.5K
CACC icon
7
Credit Acceptance
CACC
$5.82B
$125M 3.96%
284,857
-1,665
-0.6% -$698K
ROP icon
8
Roper Technologies
ROP
$40.4B
$107M 3.41%
362,346
-8,154
-2% -$2.4M
ABT icon
9
Abbott
ABT
$188B
$90.6M 2.88%
1,234,840
-102,175
-8% -$6.71M
MKL icon
10
Markel Group
MKL
$25.2B
$85.5M 2.72%
71,948
-1,153
-2% -$1.36M
LH icon
11
Labcorp
LH
$25.2B
$84.9M 2.7%
569,161
-2,657
-0.5% -$404K
GOOG icon
12
Alphabet (Google) Class C
GOOG
$4.11T
$84.6M 2.69%
1,418,440
-44,480
-3% -$2.66M
JPM icon
13
JPMorgan Chase
JPM
$916B
$72.5M 2.3%
642,487
-2,813
-0.4% -$319K
WAT icon
14
Waters Corp
WAT
$37.3B
$71.8M 2.28%
368,983
-7,505
-2% -$1.45M
WAB icon
15
Wabtec
WAB
$49.3B
$69.1M 2.19%
658,408
-35,106
-5% -$3.78M
QCOM icon
16
Qualcomm
QCOM
$164B
$67.2M 2.14%
933,395
-54,721
-6% -$3.6M
TEVA icon
17
Teva Pharmaceuticals
TEVA
$40.4B
$64.5M 2.05%
+2,993,705
New +$69.5M
BUD icon
18
AB InBev
BUD
$164B
$63.6M 2.02%
726,160
-19,664
-3% -$1.92M
JNJ icon
19
Johnson & Johnson
JNJ
$640B
$54M 1.72%
391,120
-14,253
-4% -$1.89M
EPD icon
20
Enterprise Products Partners
EPD
$83.7B
$53.8M 1.71%
1,871,072
-89,714
-5% -$2.59M
GOOGL icon
21
Alphabet (Google) Class A
GOOGL
$4.12T
$53.7M 1.71%
890,240
-52,220
-6% -$3.16M
BRK.B icon
22
Berkshire Hathaway Class B
BRK.B
$1.1T
$53.6M 1.7%
250,155
-13,564
-5% -$2.78M
AWI icon
23
Armstrong World Industries
AWI
$7.37B
$46.8M 1.49%
672,048
-7,218
-1% -$498K
BAX icon
24
Baxter International
BAX
$12.8B
$44.8M 1.42%
581,756
-178,652
-23% -$13.3M
SLB icon
25
SLB Ltd
SLB
$72.7B
$41.9M 1.33%
688,495
-39,775
-5% -$2.56M
1
2 3 4 5

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q3 2018 Portfolio in Review

As of Q3 2018, Beck Mack & Oliver held 234 positions worth $3.15B, up 5.7% from $2.98B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 3%. Beck Mack & Oliver opened 3 new positions and exited 4, leaving the 234-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Technology.

  • Beck Mack & Oliver's largest Q3 2018 buy was Teva Pharmaceuticals: 2,993,705 shares worth $64.5M.
  • Beck Mack & Oliver added most to Apollo Global Management in Q3 2018, an estimated $21.5M increase.
  • Beck Mack & Oliver's biggest Q3 2018 reduction was Merck, cutting an estimated $20.2M.
  • Beck Mack & Oliver fully exited JPMorgan Chase & Co. Depositary Shares, each representing a 1/400th interest in a share of 6.10% Non in Q3 2018, selling an estimated $211K.
  • Beck Mack & Oliver's ten largest holdings make up 39% of its $3.15B portfolio in Q3 2018.
  • Beck Mack & Oliver opened 3 new positions and closed 4 in Q3 2018.
  • Beck Mack & Oliver's portfolio value rose 5.7% quarter-over-quarter to $3.15B.

Based on Beck Mack & Oliver's 13F filing for Q3 2018, filed 29 Oct 2018.